These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36815053)

  • 21. Multifunctional Liposomes Enable Active Targeting and Twinfilin 1 Silencing to Reverse Paclitaxel Resistance in Brain Metastatic Breast Cancer.
    Du J; Shao Y; Hu Y; Chen Y; Cang J; Chen X; Pei W; Miao F; Shen Y; Muddassir M; Zhang Y; Zhang J; Teng G
    ACS Appl Mater Interfaces; 2021 May; 13(20):23396-23409. PubMed ID: 33982563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer.
    Luo A; Wu F; Han R; Huang S; Zhang Y; Jing X; Zhao X
    J Cancer Res Ther; 2017; 13(5):778-784. PubMed ID: 29237903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells.
    Hammash D; Mahfood M; Khoder G; Ahmed M; Tlili A; Hamoudi R; Harati R
    Breast Cancer (Dove Med Press); 2022; 14():187-198. PubMed ID: 35936987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic tumor microenvironment targeting and blood-brain barrier penetration via a pH-responsive dual-ligand strategy for enhanced breast cancer and brain metastasis therapy.
    Li M; Shi K; Tang X; Wei J; Cun X; Long Y; Zhang Z; He Q
    Nanomedicine; 2018 Aug; 14(6):1833-1843. PubMed ID: 29800759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer.
    Wu F; McCuaig RD; Sutton CR; Tan AHY; Jeelall Y; Bean EG; Dai J; Prasanna T; Batham J; Malik L; Yip D; Dahlstrom JE; Rao S
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31238530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
    Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
    Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer.
    Huang C; Li C; Cai J; Chen J; Wang B; Li M; Zhou W; Wang J; Zhang P; Zhang JV
    Int J Nanomedicine; 2022; 17():5547-5563. PubMed ID: 36444194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Walking Dead Tumor Cells for Targeted Drug Delivery Against Lung Metastasis of Triple-Negative Breast Cancer.
    Zhao Z; Fang L; Xiao P; Sun X; Zhou L; Liu X; Wang J; Wang G; Cao H; Zhang P; Jiang Y; Wang D; Li Y
    Adv Mater; 2022 Aug; 34(33):e2205462. PubMed ID: 35759925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual-targeting liposomes with active recognition of GLUT
    Pu Y; Zhang H; Peng Y; Fu Q; Yue Q; Zhao Y; Guo L; Wu Y
    Eur J Med Chem; 2019 Dec; 183():111720. PubMed ID: 31553933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
    Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
    J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Kasten BB; Oliver PG; Kim H; Fan J; Ferrone S; Zinn KR; Buchsbaum DJ
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer.
    Zhao Z; Li Y; Liu H; Jain A; Patel PV; Cheng K
    Sci Adv; 2020 Jul; 6(29):eabb0616. PubMed ID: 32832636
    [No Abstract]   [Full Text] [Related]  

  • 36. Insights into the Steps of Breast Cancer-Brain Metastases Development: Tumor Cell Interactions with the Blood-Brain Barrier.
    Hamester F; Stürken C; Saygi C; Qi M; Legler K; Gorzelanny C; Robador JR; Schmalfeldt B; Laakmann E; Müller V; Witzel I; Oliveira-Ferrer L
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-delivered miriplatin ultrasmall dots suppress triple negative breast cancer lung metastasis by targeting circulating tumor cells.
    Li Y; Qian D; Lin HP; Xie J; Yang P; Maddy D; Xiao Y; Huang X; Wang Z; Yang C
    J Control Release; 2021 Jan; 329():833-846. PubMed ID: 33045314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
    Ring A; Kaur P; Lang JE
    BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
    Humphries B; Wang Z; Oom AL; Fisher T; Tan D; Cui Y; Jiang Y; Yang C
    Carcinogenesis; 2014 Oct; 35(10):2254-63. PubMed ID: 24925028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer.
    Sneider A; Jadia R; Piel B; VanDyke D; Tsiros C; Rai P
    Oncomedicine; 2017; 2():1-13. PubMed ID: 28174679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.